Gainers
- SCYNEXIS Inc SCYX rose 30.6 percent to $2.69 in pre-market trading. Guggenheim Securities initiated coverage on SCYNEXIS with a Buy rating.
- Urban Outfitters, Inc. URBN rose 11.6 percent to $34.85 in pre-market trading as the company reported stronger-than-expected results for its second quarter on Tuesday.
- Valeant Pharmaceuticals Intl Inc VRX rose 9.7 percent to $29.17 in pre-market trading. Morgan Stanley upgraded Valeant from Equal-weight to Overweight and raised the price target from $33.00 to $42.00.
- Aurinia Pharmaceuticals Inc AUPH rose 6.9 percent to $2.47 in pre-market trading after surging 27.62 percent on Tuesday.
- MeetMe Inc MEET shares rose 5.4 percent to $5.29 in pre-market trading after reiterating strong guidance figures for its third quarter and full year. For Q3 management expects revenue of $17 million to $17.5 million, which compares to consensus of $17.28 million, and adjusted EBITDA of $6.5 million to $7 million, up at least 25 percent year-over-year.
- Lumber Liquidators Holdings Inc LL shares rose 4.8 percent to $17.06 in pre-market trading as the company on Tuesday announced the final resolution of Proposition 65 suit.
- Childrens Place Inc PLCE rose 4 percent to $89.27 in the pre-market trading session after the company reported better-than-expected results for the second quarter and boosted its full year outlook.
- Cardinal Financial Corporation CFNL shares rose 3 percent to $26.55 in pre-market trading. Bloomberg TV reported that
- United Bancshares Inc. UBOH is in talks to acquire Cardinal.
- Shopify Inc SHOP rose 2.1 percent to $39.16 in pre-market trading. Shopify priced its US$286,875,000 offering of Class A subordinate voting shares.
- Alere Inc ALR rose 2.1 percent to $41.25. Alere posted Q1 net loss from continuing operations of $0.18 per share on revenue of $578 million.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- StemCells Inc STEM shares fell 29.2 percent to $1.84 in pre-market trading as the company reported that it will accept warrant exercises from holders to purchase common stock issued on April 29, 2015 at a reduced exercise price of $1.10 per share. StemCells shares jumped 598.55 percent on Tuesday.
- Cree, Inc. CREE shares fell 9.4 percent to $24.90 in pre-market trading as the company reported downbeat earnings for its fourth quarter and issued a weak forecast for the current quarter.
- 21Vianet Group Inc VNET shares fell 8.1 percent to $9.66 in the pre-market trading session. 21Vianet Group reported a Q2 adjusted loss of $0.17 per ADS on revenue of $137.1 million. JP Morgan downgraded 21Vianet Group from Neutral to Underweight.
- Lowe's Companies, Inc. LOW fell 5.4 percent to $77.09 in pre-market trading as the company reported weaker-than-expected results for the second quarter and cut its earnings outlook for the full year.
- Target Corporation TGT shares dropped 4.5 percent to $72.10 in pre-market trading. Target reported better-than-expected earnings for its second quarter, but lowered its full-year profit guidance.
- INC Research Holdings Inc INCR shares fell 3.8 percent to $43.65 in pre-market trading. INC Research reported a secondary offering of 4.5 million shares common stock.
- Staples, Inc. SPLS shares fell 3.5 percent to $9.00 in pre-market trading. Staples reported in-line earnings for its second quarter, but issued a disappointing earnings forecast for the current quarter.
- Popeyes Louisiana Kitchen Inc PLKI shares fell 2.5 percent to $57.02 in pre-market trading. Popeyes posted in-line earnings for its second quarter, but sales missed analysts’ estimates. Popeye's also lowered FY 2016 system-wide same-store sales growth from a range of 2-3 percent down to 1-2 percent.
- ASML Holding NV (ADR) ASML fell 2.3 percent to $105.45 in pre-market trading. Bank of America downgraded ASML Holding from Buy to Neutral.
- Southern Co SO shares fell 2.2 percent to $49.87 in pre-market trading. Southern Company priced offering of 32.5 million shares of common stock for gross proceeds of around $1.6 billion.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in